NCT06647680 2026-03-06
Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）
The Affiliated Hospital of Qingdao University
Phase 2 Recruiting
Clinical Trials
8 trialsNCT04215731 2026-03-03
FOBEAR
Sun Yat-sen University
Phase 3 Recruiting
NCT03051464 2026-02-17
Morpheus
Sir Mortimer B. Davis - Jewish General Hospital
Phase 2/3 Recruiting
NCT03875781 2026-01-15
NORAD01
Assistance Publique - Hôpitaux de Paris
Phase 3 Recruiting
NCT06758830 2025-01-09
Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
Phase 2/3 Recruiting
NCT06300489 2024-03-08
Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer
Zhejiang Cancer Hospital
Phase 1 Recruiting
NCT04389086 2022-09-06
PelvEx II
Catharina Ziekenhuis Eindhoven
Phase 3 Recruiting
NCT03671252 2019-01-23
Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation
Sun Yat-sen University
Phase 3 Recruiting